Emerging-Market Growth Testing Government Handling Of Drug Costs
This article was originally published in PharmAsia News
India is among the world's emerging markets expected to do battle with the world's large drug makers as they attempt to negotiate affordable treatments for lifestyle diseases expected to come with growing economies.
You may also be interested in...
Non-profit approach is reassuring for healthcare payers, but vaccines won’t be ready to stop pandemic at its peak.
Executives On The Move: BMS Taps Barclays Exec For Strategy Spot, Epizyme Selects Science Chief And A Board Election At ADC Therapeutics
Bristol-Myers Squibb taps Barclays chair of global life sciences as it EVP, strategy and business development, and cancer therapeutics firm Epizyme Inc. selects a chief scientific officer. At ADC Therapeutics, an oncology drug development company, a new chairman is elected.